It was shown that CatS inhibition enhances the immunosuppressive activity of regulatory T cells under normal conditions, whereas, in the presence of tumor cells, CatS inhibits regulatory T cells and stimulates antitumor immunity by promoting CTL proliferation and survival [223]. The gene discussed is PIMREG; the disease is neoplasm.